SCHEMBL25952357

SCHEMBL25952357

COc1c(C)c(O)c(C)c(O)c1C(=O)/C=C/c1ccc(C(C)C)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.73
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ LMNA P02545 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ CXCL12 P48061 1/20 0.49
▸ KCNA3 P22001 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ TDP1 Q9NUW8 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ SLC5A1 P13866 1/20 0.43
▸ SLC5A2 P31639 1/20 0.43
▸ ABCG2 Q9UNQ0 2/20 0.43
▸ MCL1 Q07820 1/20 0.43
▸ PTGS1 P23219 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25340993 1.00 ABCB1 (0.73) ABCB1NPC1RAB9AMEN1KMT2A
SCHEMBL25340266 0.88 ABCB1 (0.57) ABCB1NPC1RAB9AMEN1KMT2A
SCHEMBL25952508 0.88 ABCB1 (0.57) ABCB1NPC1RAB9AMEN1KMT2A
SCHEMBL25340711 0.87 ABCB1 (0.76) ABCB1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL25952383 0.87 ABCB1 (0.76) ABCB1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL25340278 0.87 ABCB1 (0.80) ABCB1RAB9ALMNACXCL12KCNA3
SCHEMBL662284 0.87 ABCB1 (0.80) ABCB1RAB9AMEN1KMT2ALMNA
SCHEMBL662283 0.87 ABCB1 (0.80) ABCB1RAB9AMEN1KMT2ALMNA
SCHEMBL25952345 0.87 ABCB1 (0.80) ABCB1RAB9ALMNACXCL12KCNA3
SCHEMBL25340645 0.87 ABCB1 (0.53) ABCB1NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE LIPC, PC, CYP27A1 ABCB1 3180/4885NPC1 189/4885RAB9A 3306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback